INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 125 filers reported holding INTERSECT ENT INC in Q3 2021. The put-call ratio across all filers is 3.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $910,000 | +2.6% | 32,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $887,000 | +0.3% | 32,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $884,000 | +342.0% | 32,500 | +164.2% | 0.00% | +200.0% |
| Q3 2020 | $200,000 | +20.5% | 12,300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $166,000 | +159.4% | 12,300 | +434.8% | 0.00% | – |
| Q4 2018 | $64,000 | -83.6% | 2,300 | -83.1% | 0.00% | -100.0% |
| Q3 2018 | $391,000 | -59.6% | 13,600 | -47.5% | 0.00% | -50.0% |
| Q2 2018 | $969,000 | +4.5% | 25,900 | +9.7% | 0.00% | 0.0% |
| Q1 2018 | $927,000 | +8.0% | 23,600 | -10.9% | 0.00% | 0.0% |
| Q4 2017 | $858,000 | +4.0% | 26,500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $825,000 | +3.6% | 26,500 | -7.0% | 0.00% | 0.0% |
| Q2 2017 | $796,000 | +1183.9% | 28,500 | +612.5% | 0.00% | – |
| Q3 2014 | $62,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |